Several top tech companies such as Google, Amazon, Oracle, Microsoft, IBM and Salesforce have vowed to remove barriers which prevent customers from accessing their personal mHealth data whenever they need it. The announcement was made at the Blue Button 2.0 Developer Conference held in Washington D.C.
iBeat, a San Francisco-based start-up, launched a new pulse sensitive feature called iBeat Heart Watch which alerts healthcare professionals if it detects someone going into cardiac arrest.
DyAnsys’ Drug Relief, a wearable that is worn around the patient’s ear, is a neurostimulation therapy that helps to relieve the symptoms of opioid withdrawal such as depression, anxiety and cravings.
San Francisco-based company iBeat, an mHealth wearable development company has announced new funding from form SCOR Life & Transamerica Ventures and Health Ventures for its mHealth devices, Heart Watch which continuously monitors the heart.. iBeat did not state what the total amount was, only that the investments round was “upward of seven figures”.
Researchers are testing an mHealth wearable used for patients with asthma to see if the patch can help care teams detect pneumonia in patients undergoing radiation treatment for lung cancer.
A pioneering mHealth program has found favor with mobile health advocates. The stated program is anticipated to be useful in the treatment of people suffering from schizophrenia spectrum disorders.
A mobile health app developed by Medici is used by Kim who has stated that the technology helps him make the right connect with patients. He can log on to his smartphone or iPad when at home and make a HIPAA-compliant connection with concerned persons impacted by crisis or who would turn to medication.
Mayo Clinic researchers found success with an mHealth app - EpiFinder, which can diagnose Epilepsy (A disruption in which nerve cell activity in the brain is disturbed, causing seizures). During recent research conducted at Mayo Clinic, the Epifinder app recognized epilepsy in almost 87percent of the cases.
Video directly observed therapy (VDOT), an mHealth platform in which patients use an app to record themselves taking medications, can improve adherence and reduce costs, according to a new study.
Mobile health (mHealth) applications for clinical decision support could improve physicians’ test ordering and diagnosis decisions, according to a study published April 20 in the Journal of Informatics in Health and Biomedicine.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.